Again, inhibition of Il-1β by Il-1 receptor antagonist (Il-1Ra) or an anti-Il-1β antibody significantly suppressed aneurysm formation after AngII infusion [49], indicating that Il-1β might be a promising target for TAA and AAA treatment. Here, IL1B is linked to triple-A syndrome.